SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 21, 2008
BioMedical Technology Solutions Holdings, Inc.
(Exact name of registrant as specified in its charter)
| | |
Colorado | ____000-52652___ | 26-3161860 |
(State or other jurisdiction of incorporation or organization) | (Commission file number) | (IRS Employer Identification No.) |
9800 Mt Pyramid Court # 350
Englewood, CO 80112
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 653-0100
_ _CET Services, Inc.
12503 Euclid Dr. #30, Centennial, Colorado 80111
(Former name or former address, if changed since last report)
| |
___ | Written communications pursuant to Rule 425 under the Securities Act |
___ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
ITEM 7.01
REGULATION FD DISCLOSURE
On August 21, 2008 the Company issued a press release announcing completion of the reverse triangular merger with CET Services, Inc. A copy of the press release is attached to this Current Report.
| |
ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
99.1 | Press Release dated August 21, 2008 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| | | BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS, INC.
|
Date: August 26, 2008 | By: _/s/Donald G. Cox_____________ Donald G. Cox, President |
| | |
3
